QNCX
Quince Therapeutics, Inc.
31.00$
+3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +13.3% | +268.6% | +76.6% | +3.6% | -40.7% | +57.8% | -42.2% | -23.7% | |
| – | +307.9% | +1,226.5% | +603.8% | +106.3% | -44.3% | -68.6% | -9.1% | +7.6% | |
| – | – | +278.2% | +860.4% | +99.9% | -46.3% | – | – | – | |
| – | -184.8% | – | +437.1% | -141.7% | – | – | -124.5% | – | |
| – | +175.3% | -74.1% | -5.5% | +246.2% | -26.1% | +20.3% | +60.6% | +37.0% | |
| – | +60,619.5% | -62.0% | +195.4% | – | -69.5% | -132.0% | – | +6.0% | |
| – | – | – | – | – | – | +286.2% | – | – | |
| – | – | -323.6% | -93.9% | +44.1% | +0.0% | -87.8% | -100.0% | – | |
| – | +879.7% | +1.9% | +53.7% | -94.3% | -89.6% | -79.8% | -3,439.2% | – | |
| – | – | +50.7% | -40.7% | -81.6% | -972.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.